{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:11Z","timestamp":1786118891174,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/cad.0b013e32830cebc1","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T03:08:25Z","timestamp":1219892905000},"page":"917-920","source":"Crossref","is-referenced-by-count":15,"title":["Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma"],"prefix":"10.1097","volume":"19","author":[{"given":"Luis","family":"Villela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Borbolla-Escoboza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Bola\u00f1os-Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210203","first-page":"168","article-title":"World Health Organization Classification of Tumours. Pathology and genetics of tumours of haemathopietic and lymphoid tissues","author":"Swerdlow","year":"2001"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood.V85.6.1570.bloodjournal8561570","article-title":"CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis","volume":"85","author":"Segal","year":"1995","journal-title":"Blood"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","article-title":"Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors","volume":"82","author":"Bosch","year":"1998","journal-title":"Cancer"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","article-title":"Patterns of survival in mantle cell lymphoma","volume":"6","author":"Zucca","year":"1995","journal-title":"Ann Oncol"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","article-title":"Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period","volume":"6","author":"Norton","year":"1995","journal-title":"Ann Oncol"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V85.4.1075.bloodjournal8541075","article-title":"A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group Study","volume":"85","author":"Fisher","year":"1995","journal-title":"Blood"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood.V83.10.2829.2829","article-title":"Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical feature and outcome","volume":"83","author":"Berger","year":"1994","journal-title":"Blood"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/sj.leu.2402272","article-title":"Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype","volume":"15","author":"Bernard","year":"2001","journal-title":"Leukemia"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archneur.1997.00550190044013","article-title":"Central nervous system relapse in non-Hodgkin's lymphoma. A single-center study of 532 patients","volume":"54","author":"Bollen","year":"1997","journal-title":"Arch Neurol"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/01.MP.0000030088.28684.5B","article-title":"Cerebrospinal fluid involvement in mantle cell lymphoma","volume":"15","author":"Valdez","year":"2002","journal-title":"Mod Pathol"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s002770050491","article-title":"Central nervous system involvement in patients with mantle cell lymphoma","volume":"78","author":"Oinonen","year":"1999","journal-title":"Ann Hematol"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.1996.14.3.941","article-title":"CNS involvement in mantle cell lymphoma","volume":"14","author":"Montserrat","year":"1996","journal-title":"J Clin Oncol"},{"key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphoma at risk for central nervous system involvement: the role of flow cytometry versus cytology","volume":"105","author":"Hedge","year":"2005","journal-title":"Blood"},{"key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","article-title":"Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment","volume":"101","author":"Rubenstein","year":"2003","journal-title":"Blood"},{"key":"R16-9-20210203","first-page":"753","article-title":"Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab","volume":"88","author":"Schulz","year":"2004","journal-title":"Haematologica"},{"key":"R17-9-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11060-006-9217-y","article-title":"Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma","volume":"81","author":"Antonini","year":"2007","journal-title":"J Neurooncol"},{"key":"R18-9-20210203","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","article-title":"Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma","volume":"25","author":"Rubenstein","year":"2007","journal-title":"J Clin Oncol"},{"key":"R19-9-20210203","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1182\/blood-2002-02-0469","article-title":"In vitro mechanism of action of rituximab on primary non-Hodgkin's lymphoma","volume":"101","author":"Manches","year":"2003","journal-title":"Blood"},{"key":"R20-9-20210203","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3109\/10428190109099335","article-title":"Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma","volume":"42","author":"Harjunp\u00e4p\u00e4","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"R21-9-20210203","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdh013","article-title":"Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large B-cell lymphoma: influence of rituximab","volume":"15","author":"Feugier","year":"2004","journal-title":"Ann Oncol"},{"key":"R22-9-20210203","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/10454411950060020301","article-title":"Complement biosynthesis in the central nervous system","volume":"6","author":"Barnum","year":"1995","journal-title":"Crit Rev Oral Biol Med"},{"key":"R23-9-20210203","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neurobiolaging.2003.11.003","article-title":"Early complement activation increases in the brain in some aged normal subjects","volume":"25","author":"Loeffler","year":"2004","journal-title":"Neurobiol Aging"},{"key":"R24-9-20210203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.410400408","article-title":"Complement activation in the central nervous system following blood-brain barrier damage in man","volume":"40","author":"Lindsberg","year":"1996","journal-title":"Ann Neurol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e32830cebc1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:02:17Z","timestamp":1786035737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200810000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32830cebc1","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}